نتایج جستجو برای: میلوم متعدد multiple myeloma

تعداد نتایج: 775499  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Arianna Ferrucci Michele Moschetta Maria Antonia Frassanito Simona Berardi Ivana Catacchio Roberto Ria Vito Racanelli Antonella Caivano Antonio Giovanni Solimando Daniele Vergara Michele Maffia Dominga Latorre Antonia Rizzello Alfredo Zito Paolo Ditonno Eugenio Maiorano Domenico Ribatti Angelo Vacca

PURPOSE The aim of this study was to investigate the angiogenic role of the hepatocyte growth factor (HGF)/cMET pathway and its inhibition in bone marrow endothelial cells (EC) from patients with multiple myeloma versus from patients with monoclonal gammopathy of undetermined significance (MGUS) or benign anemia (control group). EXPERIMENTAL DESIGN The HGF/cMET pathway was evaluated in ECs fr...

Journal: :Blood 2012
Brenda M Birmann Marian L Neuhouser Bernard Rosner Demetrius Albanes Julie E Buring Graham G Giles Qing Lan I-Min Lee Mark P Purdue Nathaniel Rothman Gianluca Severi Jian-Min Yuan Kenneth C Anderson Michael Pollak Nader Rifai Patricia Hartge Ola Landgren Lawrence Lessin Jarmo Virtamo Robert B Wallace JoAnn E Manson Graham A Colditz

Insulin-like growth factor-1 (IGF-1), insulin, and IL-6 are dysregulated in multiple myeloma pathogenesis and may also contribute to multiple myeloma etiology. To examine their etiologic role, we prospectively analyzed concentrations of serologic markers in 493 multiple myeloma cases and 978 controls from 8 cohorts in the Multiple Myeloma Cohort Consortium. We computed odds ratios (ORs) and 95%...

Journal: :middle east journal of cancer 0
mehdi dehghani shiraz university of medical sciences, hematology research center, shiraz, iran vahid mohammad karimi shiraz university of medical sciences, hematology research center, shiraz, iran

we report a case of multiple myeloma that presented with anorexia, fatigue, high erythrocyte sedimentation rate, bone marrow plasmacytosis of more than 30%, polyuria,and low urine specific gravity. this unusual presentation was diagnosed as nephrogenic diabetes insipidus secondary to a proximal tubular dysfunction. the tubular functional disturbance appeared to be related to the presence of lam...

2017
Yoshiki Nakae Mizuki Hyuga Yuta Terada Wataru Kishimoto Akiko Fukunaga Sumie Tabata Yoshitomo Maesako Kenichi Komatsu Osamu Higuchi Toshinari Nakane Nobuyoshi Arima

Autoimmune autonomic ganglionopathy is an autonomic disorder that occurs as a symptom of paraneoplastic neurological syndrome. To date, there have been no reports on multiple myeloma with autoimmune autonomic ganglionopathy. A 37-year-old Japanese woman suffered from orthostatic hypotension was diagnosed with multiple myeloma (IgG kappa type), and a serological examination revealed the presence...

2012
Setu Patolia Frances Schmidt Swati Patolia Neerja Gulati Perwaiz Muhammad Dharani Narendra Danilo Enriquez Joseph Quist

Multiple myeloma - a neoplastic proliferation of plasma cell is the second most common blood cancer. Multiple myeloma is characterized by neoplastic proliferation of the plasma cells. These cells infiltrate variety of organs. Infiltration by immature neoplastic cells and overproduction of monoclonal immunoglobulin chain is responsible for clinical manifestations of multiple myeloma. The most co...

Journal: :Journal of Student Research 2023

Multiple Myeloma (MM), a bone marrow plasma cell hematopoietic cancer, remains critical but incurable hematological malignancy, prone to deadly relapses even after existing treatment. In this review, I describe the origins of pro-tumor myeloma-associated macrophages. specifically outline how classically activated anti-tumor macrophages that home cancerous tumor microenvironment is polarized int...

Journal: :Biochimica et biophysica acta 2014
M Binsfeld K Fostier J Muller F Baron R Schots Y Beguin R Heusschen J Caers

The majority of multiple myeloma patients relapse with the current treatment strategies, raising the need for alternative therapeutic approaches. Cellular immunotherapy is a rapidly evolving field and currently being translated into clinical trials with encouraging results in several cancer types, including multiple myeloma. Murine multiple myeloma models are of critical importance for the deve...

2017
Erik Lawrence Lum Neil Kogut Thu Pham Gabriel M. Danovitch Suphamai Bunnapradist

Kidney disease is a common complication in patients with multiple myeloma. Traditionally, patients with active multiple myeloma and end-stage renal disease have been excluded from kidney transplantation due to the risk of malignancy progression. The introduction of bortezomib-based therapy for patients with multiple myeloma and renal impairment has significantly improved survival in this popula...

Journal: :JAMA 2010
Ola Landgren Adam Justin Waxman

Recent data indicate that multiple myeloma is consistently preceded by the precursor states of monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma. Currently, multiple myeloma is a clinical diagnosis based on manifestations including hypercalcemia, renal failure, anemia, and bone lesions, whereas MGUS and smoldering myeloma are diagnosed based on laboratory abnormal...

Journal: :Haematologica 2011
Michael S van der Veer Michel de Weers Berris van Kessel Joost M Bakker Shulamiet Wittebol Paul W H I Parren Henk M Lokhorst Tuna Mutis

BACKGROUND In our efforts to develop novel effective treatment regimens for multiple myeloma we evaluated the potential benefits of combining the immunomodulatory drug lenalidomide with daratumumab. Daratumumab is a novel human CD38 monoclonal antibody which kills CD38+ multiple myeloma cells via antibody-dependent cell-mediated cytotoxicity, complement-dependent cytotoxicity and apoptosis. D...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید